Ever wonder how otherwise guarded investors are drawn to the high-risk frontier of scientific discovery? Join us as Doug Jamison, Chairman & CEO of Harris & Harris, takes us on a wild ride down an impressive portfolio of early stage opportunities far removed from the main stream of VC investment.
Sponsor
BlackLine Does your finance department remain bogged down in the trenches using spreadsheets to accomplish complex accounting and finance tasks? It’s time to reinvest your people’s time in high-value activities and enter the age of modern finance. Learn more. Visit www.Blackline.com/cfo
More Medicine is Moving to Silicon
“When one thinks of Samsung – one thinks of a traditional electronics company, but they are moving quickly into the life sciences sector and one of their goals is do what they did in the semi conductor industry inside medicine. They want to make it more efficient and drive the prices lower. Think of the cost of diagnostics today and how those costs have only gone up, and compare that to LED technologies and how fast they have dropped in price.”
Small IPOs on the Rise:
Related Links:
Doug’s site
A Recent Blog Post: Technologies that Will Drive Innovation and Investing in 2015